5150 El Camino Real, Suite A-32
Los Altos, CA 94022
Globavir is an infectious disease-focused company with multiple drugs in development. Our development efforts will utilize a 505(b)(2) pathway for therapeutics which will have companion diagnostic tests on the drugs' labels. Our lead program in dengue will be in Phase II in 2015. Our proprietary platform can generate multiple drug candidates which will also utilize the same 505(b)(2) pathway. Our patent protected diagnostic platform will be applicable for other infectious diseases such as: Chikungunya, Yellow Fever and Malaria.
Drug Delivery Technologies
Cell Biology; Computational Chemistry; Drug Delivery; Pharmacogenomics; Screening
Clinical Development Stage